Skip to content

Assessment of Acupuncture on Eye Fatigue

Assessment of Acupuncture on Eye Fatigue : a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06823388
Enrollment
30
Registered
2025-02-12
Start date
2024-08-01
Completion date
2025-05-30
Last updated
2025-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Accomodation, Acupuncture, Eye Fatigue

Keywords

eye fatigue, acupuncture

Brief summary

The study is designed to assess the effiacy of acupuncutre on eye fatigue. The indicator of eye fatigue is eye accommodation ability. Patients will be randomly assigned to the experimental group and the control group. The experimental group will receive acupuncture treatment, while the control group will receive sham acupuncture stimulation. The eye accommodation ability of both groups will be easured before and after the intervention, and the differences in eye accommodation ability before and after treatment will be analyzed.

Detailed description

A dual-arm, parallel, randomized single-blind, sham-controlled trial will be conducted. The aim of the study is to assess the effiacy of acupuncutre on eye fatigue. Patients will be recruited from outpatient clinics. Subjects will be assessed at a Traditional Chinese Medicine (TCM) outpatient clinic and then have their accommodation function tested in an optometry room . This will determine if they meet the inclusion criteria. Those who meet the inclusion criteria will be randomly assigned to the experimental group or the control group. The experimental group will receive treatment at seven acupuncture points: Fengfu (GV16), bilateral Fengchi (GB20), Yumen (TH2), and Hegu (LI4), using Jiasun 42G 1-inch acupuncture needles. The needles will be inserted perpendicularly to achieve the De Qi sensation, with a depth of 0.5 inches, and retained for 25 minutes before removal. The control group will undergo sham acupuncture at the same points using specially designed acupuncture needles from the manufacturer, which give the sensation of needling but retract into the handle without penetrating the skin, thus providing no real stimulation. Both groups will be treated by TCM physician . After needle removal, visual acuity will be tested again to compare the differences in values between the pre- and post-test measurements of both groups.

Interventions

DEVICEacupuncture

acupuncture

DEVICEpseudo-acupuncture

The pseudo-acupuncture device can simulate the sensation of acupuncture stimulation.

Sponsors

Chung Shan Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjective experience of eye fatigue after using electronic devices at least twice a week. * Age ≥ 18 years. * Agreement to sign the informed consent form for this study.

Exclusion criteria

* Accommodation assessment: Interocular accommodation difference greater than 3 diopters (D). * History of metabolic diseases with accompanying retinal conditions (e.g., diabetic retinopathy, hypertensive/hyperlipidemic patients with macular edema, retinal hemorrhage, glaucoma, etc.). * Current treatment for ocular inflammation or infection (e.g., conjunctivitis, orbital cellulitis). * Underwent eye surgery within the last 3 months (including LASIK surgery). * Received acupuncture treatment for eye-related symptoms in the past month. * Diagnosed with severe ophthalmic conditions (e.g., optic atrophy) and deemed unsuitable for the trial by an ophthalmologist. * Diagnosed with anemia, hypotension, or chronic fatigue in the past three months, making them unsuitable for acupuncture due to a tendency to faint. * Pregnant women. * Major diseases such as renal insufficiency, cerebrovascular disease, or cancer, deemed unsuitable for clinical research participation by the principal investigator.

Design outcomes

Primary

MeasureTime frameDescription
eye accommodation abilityFrom enrollment to the end of treatment in 30 minutesValue of eye accommodation ability difference before and after the intervention, measured by an autorefractor

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026